Pyrazoline derivatives useful for the treatment of cancer

Details for Australian Patent Application No. 2005212833 (hide)

Owner Laboratorios Del Dr. Esteve S.A.

Inventors Cuberes Altisen, Rosa; Casanova Rigal, Isolda; Mangues Bafalluy, Ramon; Frigola Constansa, Jordi

Agent Collison & Co

Pub. Number AU-A-2005212833

PCT Pub. Number WO2005/077910

Priority 10/804,695 19.03.04 US; 200400362 16.02.04 ES

Filing date 16 February 2005

Wipo publication date 25 August 2005

International Classifications

C07D 231/06 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

Event Publications

7 September 2006 PCT application entered the National Phase

  PCT publication WO2005/077910 Priority application(s): WO2005/077910

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005212834-Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments

2005212832-7H-pyrrolopyrimidine derivatives